![Kamel Besseghir](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kamel Besseghir
Directeur/Membre du Conseil chez
ONCODESIGN
Profil
Kamel Besseghir is currently an Independent Director at Oncodesign SA since 2014 and a Director at Oncodesign Precision Medicine SA since 2022.
Formerly, Dr. Besseghir was Chief Executive Officer at Debiopharm International SA from 1995 to 2012.
Other former roles include Principal positions at Serono SA, The State University of New York, and the University of Lausanne.
Postes actifs de Kamel Besseghir
| Sociétés | Poste | Début |
|---|---|---|
| ONCODESIGN | Directeur/Membre du Conseil | 03/02/2014 |
| ONCODESIGN PRECISION MEDICINE | Directeur/Membre du Conseil | 14/09/2022 |
Anciens postes connus de Kamel Besseghir
| Sociétés | Poste | Fin |
|---|---|---|
Debiopharm International SA
 Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | President | 01/01/2012 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Corporate Officer/Principal | - |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Health Technology |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
Oncodesign Precision Medicine SA
 Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology | Health Technology |
